Certainly! Here is detailed information about Infliximab based on the provided context:

Inflectra (Infliximab-dyyb) Overview
- Type: Biologic Disease-Modifying Antirheumatic Drug (DMARD)
- Approval: FDA-approved to reduce signs and symptoms of active ankylosing spondylitis
- Biosimilar: Inflectra is a biosimilar of Remic Show Full Answer

Certainly! Here is detailed information about Infliximab based on the provided context:

Inflectra (Infliximab-dyyb) Overview
- Type: Biologic Disease-Modifying Antirheumatic Drug (DMARD)
- Approval: FDA-approved to reduce signs and symptoms of active ankylosing spondylitis.
- Biosimilar: Inflectra is a biosimilar of Remicade. A biosimilar is a biological product highly similar to an already-approved biological product.

Mechanism of Action
- Function: Inflectra is an immunomodulator that modulates the immune system.
- Target: It works by attaching to tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks.
- Action: Inflectra binds to TNF-α and prevents it from signaling the immune system to attack.

Administration
- Form: Available in vial form.
- Method: Administered as an intravenous infusion in a medical setting.
- Frequency: Every six or eight weeks after initial loading doses.

Side Effects
- Common Side Effects:
- Headache
- Cold and flu symptoms
- Infusion reactions
- Abdominal pain
- Rare but Serious Side Effects:
- Blood disorders
- Severe infections
- Increased risk for certain types of cancer
- Liver or heart failure
- Severe allergic reactions
- Development of lupus-like syndrome or demyelinating disease such as multiple sclerosis

Additional Resources
- For answers to frequently asked questions about exposure to Infliximab during pregnancy and breastfeeding, visit the experts at [MothertoBaby.org](https://www.mothertobaby.org).

For more details about this treatment, you can visit the [Inflectra page on MySpondylitisTeam](https://www.MySpondylitisTeam.com/treatments/in...).

 This AI-generated response comes from MySpondylitisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Inflectra (Infliximab-dyyb) for Spondylitis | MySpondylitisTeam

Remicade (Infliximab) for Spondylitis | MySpondylitisTeam